Shree Ganesh Bio-Tech Share Price Today | Stock Price & Shree Ganesh Bio-Tech Share Screener
As of October 5, 2026, the live Shree Ganesh Bio-Tech share price (BSE: SHREEGANES) is ₹0.47, unchanged from the previous close, with shares trading between ₹0.47 and ₹0.49 in today's trading session, and a 52-week range of ₹0.46–₹0.75. Check SHREEGANES annual price range for the annual price range and momentum. Use the Shree Ganesh Bio-Tech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Shree Ganesh Bio-Tech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹7 and net income of ₹-1, with EBITDA of ₹-1, an operating margin of -35.0% and a profit margin of -14.3%.
Shree Ganesh Bio-Tech Share Price Chart
Track the current stock price of Shree Ganesh Bio-Tech with an interactive chart. Analyse SHREEGANES share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Shree Ganesh Bio-Tech stock quote in one place.
The quote of ₹0.47 sits between the 52-week low of ₹0.46 and the 52-week high of ₹0.75.
Shree Ganesh Bio-Tech Company Profile - Fundamental Screener
Screen Shree Ganesh Bio-Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHREEGANES shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Biotechnology industry, and it trades under ISIN INE051N01026.
Company Details
Classification
Identifiers and Leadership
Shree Ganesh Bio-Tech Balance Sheet Screener
Screen SHREEGANES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹64, down from ₹64 in 2025.
Latest statistics put total assets at ₹64 and shareholder funds at ₹64.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 64 | 64 | 74 | 80 | 94 | 75 | 65 | 64 | 26 | 19 |
| Current Assets | 12 | 3 | 4 | 20 | 44 | 28 | 21 | 19 | 14 | 9 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 64 | 63 | 63 | 62 | 60 | 58 | 58 | 57 | 23 | 19 |
| Share Capital | 40 | 40 | 40 | 40 | 20 | 20 | 20 | 20 | 2 | 2 |
| Reserves & Surplus | 24 | 23 | 23 | 23 | 40 | 38 | 38 | 37 | 10 | 7 |
Shree Ganesh Bio-Tech Income Statement Screener - Profit & Revenue Analysis
Screen Shree Ganesh Bio-Tech income statement and profit fundamentals. Analyze SHREEGANES quarterly results. Shree Ganesh Bio-Tech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹7 and net profit was ₹-1, at an operating margin of -35%.
In that period expenses were ₹7, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹6 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 7 | 6 | 24 | 21 | 63 | 73 | 17 | 3 | 6 | 8 | 9 | 2 | 2 |
| Expenses | 7 | 6 | 24 | 21 | 60 | 69 | 17 | 2 | 4 | 4 | 5 | 2 | 1 |
Operating Costs and Margins | |||||||||||||
| EBITDA | -1 | 1 | 0 | 1 | 3 | 4 | 1 | 0 | 2 | 4 | 4 | 1 | 1 |
| Operating Profit % | -35.00% | -19.00% | -5.00% | -1.00% | 3.00% | 5.00% | 4.00% | 10.00% | 31.00% | 45.00% | 44.00% | 31.00% | 30.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | -1 | 1 | 0 | 1 | 3 | 4 | 0 | 0 | 2 | 4 | 4 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | 0 | 0 | 1 | 2 | 3 | 0 | 0 | 2 | 4 | 4 | 1 | 0 |
| EPS | 0.00 | 0.01 | 0.01 | 0.02 | 0.05 | 0.13 | 0.16 | 0.12 | 0.90 | 19.12 | 20.39 | 2.94 | 1.88 |
Shree Ganesh Bio-Tech Cash Flow Screener - Liquidity Fundamentals
Screen SHREEGANES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹8.
Over the same period, investing activities provided ₹8 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -8 | -10 | 10 | 11 | 4 | 2 | -1 | -1 | 2 | -13 |
| Investing Activities | 8 | 10 | -10 | -10 | -3 | -2 | 1 | -32 | -2 | 3 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 0 | 10 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shree Ganesh Bio-Tech Shareholding Pattern Screener
See Shree Ganesh Bio-Tech shareholding pattern with promoter, FII, and DII holdings. Check Shree Ganesh Bio-Tech promoter holding and ownership changes for SHREEGANES on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 0.00%, foreign institutions 1.42%, domestic institutions 0.00% and the public 95.33%, spread across 183,658 shareholders.
The shareholder count was 183,658 in 2026-Mar, compared with 181,722 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Institutional Investors | ||||||||
| FII Holding | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 95.33% | 95.36% | 95.24% | 95.30% | 95.27% | 95.40% | 94.65% | 95.39% |
| Other Holding | 3.25% | 3.22% | 3.34% | 3.28% | 3.31% | 3.18% | 3.93% | 3.19% |
| Shareholder Count | 183,658 | 181,722 | 195,435 | 192,235 | 189,375 | 186,148 | 176,722 | 181,198 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Shree Ganesh Bio-Tech. Shree Ganesh Bio-Tech dividend yield can be compared with peers and other stocks in the market.
Shree Ganesh Bio-Tech Stock Index Membership - Nifty & Sensex
See which indices include Shree Ganesh Bio-Tech stock. Check SHREEGANES index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Shree Ganesh Bio-Tech Market Events Screener - Corporate Actions
Get Shree Ganesh Bio-Tech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Shree Ganesh Bio-Tech stock events that may affect SHREEGANES share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.
It is followed by Quarterly Result Announcement dated August 4, 2026 and Quarterly Result Announcement dated May 14, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | -2.08% |
| 2026-08-04 | 2026-08-04 | Quarterly Result Announcement | NA | -3.57% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | -1.64% |
| 2026-01-29 | 2026-01-29 | Quarterly Result Announcement | NA | 0.00% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -1.35% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | -1.28% |
| 2025-07-25 | 2025-07-25 | Quarterly Result Announcement | NA | -2.41% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 5.88% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -4.04% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -4.59% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -4.46% |
| 2022-04-27 | 2022-04-28 | Bonus | 1:1 | -26.76% |
Shree Ganesh Bio-Tech Competitors Screener - Peer Stocks Comparison
Screen SHREEGANES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 6 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 48,440 | 83.28 | 2,280 | 18.12% | 592 | 36.45 |
| Advanced Enzyme Tech | 3,169 | 18.50 | 781 | 16.51% | 174 | 35.27 |
| CCME Global | 208 | -254.68 | 4 | % | 0 | 55.93 |
| Vivo Bio Tech | 37 | -12.79 | 54 | 4.47% | -2 | 34.06 |
| Shree Ganesh Bio-Tech | 19 | -46.00 | 6 | -73.77% | 0 | 32.55 |
| Genomic Valley Biotech | 9 | 414.29 | 0 | -66.25% | 0 | 47.00 |
Shree Ganesh Bio-Tech Company Announcements - News & Reports Screener
Screen SHREEGANES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated and September 17, 2026.
| Date | Update | Actions |
|---|---|---|
| Shareholder Meeting / Postal Ballot-Scrutinizers Report | - | |
| Shareholder Meeting / Postal Ballot-Outcome of AGM | - | |
| 2026-09-17 | Closure of Trading Window | - |
| 2026-09-03 | Reg. 34 (1) Annual Report. | - |
| 2026-09-03 | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-09-03 | Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-09-01 | Updation In The Website Of The Company | - |
| 2026-08-04 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-04 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-08-04 | Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th August 2026. | - |
| 2026-07-21 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-12 | Closure of Trading Window | - |
| 2026-05-23 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-14 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-14 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-05-14 | Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026. | - |
| 2026-05-04 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | - |
| 2026-04-23 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹0.47, within a 52-week range of ₹0.46 to ₹0.75. The P/B ratio is 0.29. Market capitalisation stands at ₹18.70 Cr. The company operates in the Healthcare sector, in the Biotechnology industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.